Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

NCT02458079 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.

NCT NCT02458079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02458079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis
Lead sponsor
Institute of Liver and Biliary Sciences, India
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2014
Completion date
July 27, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis